CRH PUBLIC LTD CO
No SEC Form 4 filings for $CRH in the last 30 days.
See all $CRH insider activity →CRH plc reported Q2 2026 results with higher year-on-year revenue and net income, raised its quarterly dividend to $0.39 per share, and reaffirmed full-year 2026 earnings guidance. The company also continued a multi-year share buyback program. The article cites 2026 net income guidance of $3.9B to $4.1B and projects $46.8B revenue and $5.6B earnings by 2029.
The U.S. Justice Department and Tennessee’s attorney general intervened in CRH’s subsidiary APAC-Tennessee’s planned purchase of Standard Construction, alleging the deal could reduce competition and raise asphalt prices for the Tennessee DOT. As part of a settlement, APAC-Tennessee will divest two hot-mix asphalt plants in western Tennessee to Dunn Construction.
CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.
Over the past 7 days, alphai's AI scored 4 news stories mentioning CRH (CRH PUBLIC LTD CO). Coverage has skewed bullish: 1 bullish, 3 neutral, and 0 bearish.
Recent CRH coverage spans mergers & acquisitions, earnings and regulation.
The article frames CRH’s beat plus capital returns as reinforcing its 2026 earnings narrative, while highlighting U.S. infrastructure funding risk as the key offset.
DOJ antitrust intervention forces asset divestitures tied to CRH’s acquisition, creating deal-structure and execution risk.
Deal economics are attractive on paper (synergies, accretion), but leverage and integration execution are the near-term swing factors for CRH’s credit and equity risk.
The dismissal reduces near-term litigation risk for CRH Healthcare related to tracking pixels, but the plaintiff has 14 days to refile, keeping some uncertainty.
Positive read-through for CRH’s aggregates and critical infrastructure exposure, partially offset by slower cement pricing in the Americas Materials Solutions division.
alphai scores every news story that mentions CRH with an AI model for sentiment and relevance, and aggregates insider trades from CRH PUBLIC LTD CO's SEC EDGAR Form 4 filings. Figures refresh continuously.
CRH plc reported Q2 2026 results with higher year-on-year revenue and net income, raised its quarterly dividend to $0.39 per share, and reaffirmed full-year 2026 earnings guidance. The company also continued a multi-year share buyback program. The article cites 2026 net income guidance of $3.9B to $4.1B and projects $46.8B revenue and $5.6B earnings by 2029.
6 min readThe U.S. Justice Department and Tennessee’s attorney general intervened in CRH’s subsidiary APAC-Tennessee’s planned purchase of Standard Construction, alleging the deal could reduce competition and raise asphalt prices for the Tennessee DOT. As part of a settlement, APAC-Tennessee will divest two hot-mix asphalt plants in western Tennessee to Dunn Construction.
5 min readCRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.
6 min readA federal judge dismissed a proposed class action against CRH Healthcare, doing business as Peachtree Immediate Care, over claims that website tracking technologies (including Google Analytics) transmitted patients’ protected health information to third parties. The court said the plaintiff failed to show compensable damages and found an ECPA exemption for parties to the communication. The plaintiff has 14 days to amend.
6 min readGlobal Cement Newsletter reviews 1H 2026 results for major cement producers outside China. CRH sales rose on Eco Material Technologies and higher aggregates prices; Heidelberg Materials saw slight cement revenue declines except North America; Holcim reported 5% organic growth. Cemex’s Mexico strength lifted sales and volumes; UltraTech Cement sales rose 16% YoY to US$2.57bn in 1Q FY2027. Also covers Ararat Cement management change, IKN Czech appointment, and Mitsubishi UBE Cement IPO plans.
7 min readCRH said it acquired Pisgah Stone Products LLC to expand its Northern Utah aggregates network via CRH Americas Materials. The deal adds Pisgah quarry operations in Wellsville, Utah, supplying hard-rock limestone for asphalt and ready-mixed concrete. Financial terms were not disclosed. CRH cited strong regional population and infrastructure demand.
3 min readCRH’s Americas Materials unit said it acquired Pisgah Stone Products LLC, a Northern Utah aggregates producer. CRH expects the deal to add hard-rock limestone reserves to support its long-term regional strategy amid construction and infrastructure demand. Pisgah, based in Wellsville, supplies limestone for asphalt and concrete, serving business and government customers.
2 min readCRH reported 2Q26 revenues of US$10.8bn, up 6% year over year, and net income up 13% to US$1.5bn. Adjusted EBITDA rose 7% to US$2.6bn, with margins improving. CRH completed three non-core divestments and invested US$1.4bn in 17 acquisitions YTD, and agreed to buy Arcosa for US$8.5bn. It reaffirmed 2026 guidance: net income US$3.9-4.1bn, adjusted EBITDA US$8.1-8.5bn, EPS US$5.60-6.05.
4 min readCNBC’s Jim Cramer warned investors against buying AI or data-center stocks on margin as U.S. margin debt rose above $1.5 trillion. FINRA reported June debit balances at $1.502T, up 49% from a year earlier. Cramer said margin can trigger forced selling if prices fall. He cited CRH (CRH) as a more diversified data-center-linked option, noting Q1 revenue of $7.37B and guidance for 2025 net income $3.9B-$4.1B.
6 min readCRH shares fell about 1% after Q2 2026 earnings, following declines of roughly 10% over one month and 18% over three months. In Q2 2026, CRH reported US$10.8b revenue and adjusted EBITDA of over US$2.6b, with adjusted EPS of US$2.23. Management kept full-year guidance and emphasized margin expansion, while deal and integration risks were cited.
6 min read
